ClinicalTrials.gg
RecruitingNCT07855445Updated Oct 7, 2026

Neuropathic Pain Severity and Its Association With Radiological Findings in Lumbar Spinal Stenosis

An observational study in Spinal Stenosis Lumbar and Neuropathic Pain, sponsored by Marmara University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by Marmara University · Observational

How we know

From the registry’s dates

  • Started Oct 2026; still recruiting 1 month later.
Updated Oct 7, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
100
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 79 studies in Neuralgia with a site in Turkey — 29 open to participants now, 30 under way, none of them phase 3. Neuralgia · Turkey.

Planned enrollment
18th of 43
100 · median 96
Started
2026
with 18 others
Observational
43 of 79
15 open now
Primary completion
2027-02
later than 20 of 29 live
Registered
79th of 79
by date
Lead sponsor
7 of 79
Marmara University

Among the 79 studies in Neuralgia with a site in Turkey, this one is the 18th largest by planned enrollment of the 43 observational ones that give a count, is one of 19 that started in 2026, is one of 43 observational ones, reaches primary completion later than 20 of the 29 other live ones, and was the 79th registered.

Neuralgia

1,103 studies on the registry are indexed under Neuralgia; 243 are open to participants now.

Browse Neuralgia studies →

Open to participants now

29 of the 79 studies in Neuralgia with a site in Turkey are open now. Recruiting first, the newest first:

23 more — sign in →

All 29 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 155 Neuralgia studies recruiting now, 79 (51%) set no upper age limit and 44 (28%) stop at 75 or younger; 8 take children under 18; 12 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 79 studies in Neuralgia with a site in Turkey, or all of them as a file.
02

Study summary

This cross-sectional observational study aims to evaluate neuropathic pain severity in patients with lumbar spinal stenosis (LSS) and to investigate its association with radiological findings. Neuropathic pain will be evaluated using the Neuropathic Pain Symptom Inventory (NPSI). Pain intensity, neuropathic pain characteristics, functional status, walking capacity, and psychological symptoms will also be assessed. The relationships between NPSI scores and clinical, functional, psychological, and radiological parameters will be investigated.

03

Conditions studied

  • Spinal Stenosis Lumbar
  • Neuropathic Pain

Keywords

  • Neuropathic pain
  • Spinal stenosis
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients with clinically and radiologically confirmed lumbar spinal stenosis who present with low back and/or leg pain or symptoms of neurogenic claudication.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥18 years.
  • Diagnosis of lumbar spinal stenosis based on clinical evaluation and lumbar magnetic resonance imaging findings.
  • Presence of low back and/or leg pain or symptoms of neurogenic claudication.
  • Sufficient cognitive ability to understand and complete the study questionnaires.

Exclusion criteria

Exclusion Criteria:

  • Presence of diabetic neuropathy, polyneuropathy, peripheral nerve entrapment neuropathy, or other causes of neuropathic pain.
  • Acute symptomatic lumbar disc herniation considered to be the primary cause of radicular symptoms.
  • Active or a history of spinal .
  • History of major lumbar spine surgery, such as lumbar fusion.
  • Severe psychiatric disorder or cognitive impairment that prevents reliable completion of the study questionnaires.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients with Lumbar Spinal Stenosis

    Patients diagnosed with lumbar spinal stenosis based on clinical and magnetic resonance imaging (MRI) findings. Participants will undergo a single cross-sectional assessment including neuropathic pain symptoms, pain intensity, functional status, walking capacity, psychological symptoms, and radiological severity.

06

What researchers measure

Primary outcomes

  1. Neuropathic Pain Symptom Inventory Total Intensity Score

    Neuropathic pain symptom intensity will be assessed using the Neuropathic Pain Symptom Inventory (NPSI). The total intensity score is calculated as the sum of 10 symptom descriptor scores and ranges from 0 to 100, with higher scores indicating greater neuropathic pain symptom intensity.

    Time frame: Single assessment at baseline

Secondary outcomes

  1. Correlation Between Neuropathic Pain Symptom Inventory Total Intensity Score and Radiological Severity of Lumbar Spinal Stenosis

    The correlation between the Neuropathic Pain Symptom Inventory (NPSI) total intensity score (range, 0-100; higher scores indicate greater neuropathic pain symptom intensity) and radiological severity of lumbar spinal stenosis assessed on lumbar magnetic resonance imaging using the Schizas grading system will be evaluated.

    Time frame: Single assessment at baseline

  2. Correlation Between Neuropathic Pain Symptom Inventory Total Intensity Score and Leg Pain Intensity

    The correlation between the NPSI total intensity score (range, 0-100; higher scores indicate greater neuropathic pain symptom intensity) and leg pain intensity assessed using the 11-point Numeric Rating Scale (NRS; 0 = no pain and 10 = worst imaginable pain) will be evaluated.

    Time frame: Single assessment at baseline

  3. Correlation Between Neuropathic Pain Symptom Inventory Total Intensity Score and Functional Disability

    The correlation between the NPSI total intensity score (range, 0-100; higher scores indicate greater neuropathic pain symptom intensity) and functional disability assessed using the Oswestry Disability Index (ODI) will be evaluated. Higher ODI scores indicate greater disability.

    Time frame: Single assessment at baseline

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data are not planned to be shared publicly due to participant confidentiality and data protection considerations.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2026 (actual). Primary completion is estimated for Feb 2027, 4 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 28, 2026
First posted
Oct 2, 2026
StartActual
Oct 2, 2026
Primary completionEst.
Feb 2027
CompletionEst.
Mar 2027
Last update
Oct 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 7, 2026
Sites
Marmara University Pendik Training and Research Hospital is now Recruiting
Oct 7, 2026
Secondary outcomes
3 edited
What changed in the outcomes
  • EditedAssociationCorrelation Between Neuropathic Pain SeveritySymptom Inventory Total Intensity Score and Radiological Severity of Lumbar Spinal StenosisTime frame: Single assessment at baseline
  • EditedAssociationCorrelation Between Neuropathic Pain SeveritySymptom Inventory Total Intensity Score and ClinicalLeg Pain IntensityTime frame: Single assessment at baseline
  • EditedAssociationCorrelation Between Neuropathic Pain SeveritySymptom Inventory Total Intensity Score and Functional StatusDisabilityTime frame: Single assessment at baseline
Oct 7, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Marmara University Pendik Training and Research Hospital · Istanbul, Turkey (Türkiye)Contact added n•••@gmail.com · •••4545
Oct 7, 2026
Registered
First appeared on the registry
Oct 2, 2026
Show all 2 updates
  1. Oct 7, 2026
    Not yet recruiting→Recruiting
    Marmara University Pendik Training and Research Hospital is now Recruiting
    Secondary outcomes 3 edited
    What changed in the outcomes
    • EditedAssociationCorrelation Between Neuropathic Pain SeveritySymptom Inventory Total Intensity Score and Radiological Severity of Lumbar Spinal StenosisTime frame: Single assessment at baseline
    • EditedAssociationCorrelation Between Neuropathic Pain SeveritySymptom Inventory Total Intensity Score and ClinicalLeg Pain IntensityTime frame: Single assessment at baseline
    • EditedAssociationCorrelation Between Neuropathic Pain SeveritySymptom Inventory Total Intensity Score and Functional StatusDisabilityTime frame: Single assessment at baseline
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Marmara University Pendik Training and Research Hospital · Istanbul, Turkey (Türkiye)Contact added n•••@gmail.com · •••4545
    + 2 other changes: verification date and date precision
  2. Oct 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07855445
Lead sponsor
Marmara University
Responsible party
Sponsor
First posted
Oct 2, 2026
Start date
Oct 2, 2026
Primary completion
Feb 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Oct 7, 2026

Study contacts

Nurbanu Hindioglu Dogan
Contact
nurbanuhindioglu@gmail.com
+90 216 625 45 45

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion